Endocrine therapy in the treatment of metastatic breast cancer

被引：73

作者：

Buzdar, AU ^{[1
]}

机构：

[1] MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77037 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 03期

关键词：

D O I：

10.1053/sonc.2001.23495

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：291 / 304

页数：14

共 94 条

[81]

ROSS MB, 1985, CANCER, V55, P341, DOI 10.1002/1097-0142(19850115)55:2<341::AID-CNCR2820550206>3.0.CO

[82]

2-7

[83] SERUM-LIPOPROTEINS AND PROTEINS AFTER BREAST-CANCER SURGERY AND EFFECTS OF TAMOXIFEN [J].

ROSSNER, S ;

WALLGREN, A .

ATHEROSCLEROSIS, 1984, 52 (03) :339-346

[84] THE ROLE OF PROGESTINS AND PROGESTERONE RECEPTORS IN THE TREATMENT OF BREAST-CANCER [J].

SEDLACEK, SM ;

HORWITZ, KB .

STEROIDS, 1984, 44 (06) :467-484

[85]

STEEG P, 1996, DIS BREAST, P284

[86] ANGIOGENESIS AND CANCER METASTASES - THERAPEUTIC APPROACHES [J].

TEICHER, BA .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1995, 20 (1-2) :9-39

[87] Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study [J].

Thurlimann, B ;

Paridaens, R ;

Serin, D ;

Bonneterre, J ;

Roche, H ;

Murray, R ;

diSalle, E ;

Lanzalone, S ;

Zurlo, MG ;

Piscitelli, G .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1767-1773

[88] TAT-59, A NEW TRIPHENYLETHYLENE DERIVATIVE WITH ANTITUMOR-ACTIVITY AGAINST HORMONE-DEPENDENT TUMORS [J].

TOKO, T ;

SUGIMOTO, Y ;

MATSUO, K ;

YAMASAKI, R ;

TAKEDA, S ;

WIERZBA, K ;

ASAO, T ;

YAMADA, Y .

EUROPEAN JOURNAL OF CANCER, 1990, 26 (03) :397-404

[89]

TOMAS E, 1995, GYNECOL ONCOL, V59, P261

[90] MULTICENTER PHASE-II EFFICACY TRIAL OF TOREMIFENE IN TAMOXIFEN-REFRACTORY PATIENTS WITH ADVANCED BREAST-CANCER [J].

VOGEL, CL ;

SHEMANO, I ;

SCHOENFELDER, J ;

GAMS, RA ;

GREEN, MR .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :345-350

← 1 2 3 4 5 6 7 8 9 10 →